A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
Public ClinicalTrials.gov record NCT03440814. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
Study identification
- NCT ID
- NCT03440814
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Soleno Therapeutics, Inc.
- Industry
- Enrollment
- 127 participants
Conditions and interventions
Conditions
Interventions
- DCCR Drug
- Placebo for DCCR Drug
Drug
Eligibility (public fields only)
- Age range
- 4 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 8, 2018
- Primary completion
- Apr 30, 2020
- Completion
- Apr 30, 2020
- Last update posted
- Sep 20, 2023
2018 – 2020
United States locations
- U.S. sites
- 20
- U.S. states
- 17
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, Irvine | Orange | California | 92868 | — |
| Stanford University | Palo Alto | California | 94305 | — |
| Rady Children's Hospital San Diego | San Diego | California | 92123 | — |
| Children's Hospital Colorado | Aurora | Colorado | 80045 | — |
| University of Florida Gainesville | Gainesville | Florida | 32608 | — |
| Emory Children's Center | Atlanta | Georgia | 30322 | — |
| Indiana University School of Medicine | Indianapolis | Indiana | 46202 | — |
| Kansas University Medical Center | Kansas City | Kansas | 66160 | — |
| National Institutes of Health Hatfield Clinical Research Center | Bethesda | Maryland | 20892 | — |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | — |
| Sparrow Clinical Research Institute | Lansing | Michigan | 48912 | — |
| Children's Minnesota | Saint Paul | Minnesota | 55102 | — |
| St. Joseph's University Medical Center | Paterson | New Jersey | 07503 | — |
| NYU Winthrop Hospital | Mineola | New York | 11501 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| The Research Institute at Nationwide Children's Hospital | Columbus | Ohio | 43205 | — |
| Vanderbilt University | Nashville | Tennessee | 37232 | — |
| Research Institute of Dallas | Dallas | Texas | 75231 | — |
| University of Utah | Salt Lake City | Utah | 84113 | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03440814, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 20, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03440814 live on ClinicalTrials.gov.